CaM specifically interacts with TBC1D3 in a Ca2+-dependent manner and inhibits GF signaling-induced ubiquitination and degradation of the oncoprotein in both cytoplasm and the nucleus of human breast cancer cells. The gene discussed is TBC1D3; the disease is breast carcinoma.